| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42001299 | EBV | ENSG00000153113.25 | lncRNA | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS42001300 | EBV | ENSG00000153113.25 | lncRNA | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10001775 | HBV | ENSG00000153113.25 | lncRNA | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10001775 | HBV | ENSG00000310517.1 | protein_coding | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10009684 | HBV | ENSG00000153113.25 | lncRNA | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10009684 | HBV | ENSG00000310517.1 | protein_coding | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10021253 | HBV | ENSG00000153113.25 | lncRNA | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10021253 | HBV | ENSG00000310517.1 | protein_coding | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10023543 | HBV | ENSG00000153113.25 | lncRNA | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
| TVIS10023543 | HBV | ENSG00000310517.1 | protein_coding | CAST | No | No | 831 | E9PCH5 E9PDE4 P20810 Q86YM9 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CAST |
|---|---|
| DrugBank ID | DB01373 |
| Drug Name | Calcium |
| Target ID | BE0000904 |
| UniProt ID | P20810 |
| Regulation Type | |
| PubMed IDs | 17543955; 17570336 |
| Citations | Hanna RA, Garcia-Diaz BE, Davies PL: Calpastatin simultaneously binds four calpains with different kinetic constants. FEBS Lett. 2007 Jun 26;581(16):2894-8. Epub 2007 May 25.@@De Tullio R, Averna M, Stifanese R, Parr T, Bardsley RG, Pontremoli S, Melloni E: Multiple rat brain calpastatin forms are produced by distinct starting points and alternative splicing of the N-terminal exons. Arch Biochem Biophys. 2007 Sep 1;465(1):148-56. Epub 2007 May 30. |
| Groups | Nutraceutical |
| Direct Classification | |
| SMILES | [Ca] |
| Pathways | Lidocaine (Antiarrhythmic) Action Pathway; Reteplase Action Pathway; Arachidonic Acid Metabolism; Oxaprozin Action Pathway; Ardeparin Action Pathway; Heparin Action Pathway; Mefenamic Acid Action Pathway; Bromfenac Action Pathway; Riboflavin Metabolism; Alprenolol Action Pathway; Naproxen Action Pathway; Procainamide (Antiarrhythmic) Action Pathway; Sphingolipid Metabolism; Tranexamic Acid Action Pathway; Xanthine Dehydrogenase Deficiency (Xanthinuria); Meloxicam Action Pathway; Phenprocoumon Action Pathway; Streptokinase Action Pathway; Phenylketonuria; Gaucher Disease; Fc Epsilon Receptor I Signaling in Mast Cells; Ketorolac Action Pathway; Androgen and Estrogen Metabolism; Acetylsalicylic Acid Action Pathway; Bivalirudin Action Pathway; Aprotinin Action Pathway; Alpha Linolenic Acid and Linoleic Acid Metabolism; Malate-Aspartate Shuttle; Folate Metabolism; Adenylosuccinate Lyase Deficiency |
| PharmGKB | PA164712582 |
| ChEMBL |
